selcodebart
selcodebart: developed by 1 company · 3 clinical trials tracked.
selcodebart evidence translation
What we can confirm
3 tracked trials
What it means
What to watch
Prepared research question
How could selcodebart → IRON affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence5 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Disc Medicine, Inc. (IRON) Chronic Kidney Diseases; Inflammatory Bowel Disease (IBD); M… | Phase 2 |
Clinical Trials (3)
RALLY-IBD: A Phase 2 Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of DISC-0974 in Participants With Inflammatory Bowel Disease and Anemia of Inflammation
Primary endpoint: Maximal change from baseline in Hgb through Day 85
A Phase 1b Multicenter, Randomized, Double-Blind, Placebo-Controlled Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DISC-0974 in Participants With Non-Dialysis Dependent Chronic Kidney Disease and Anemia
Primary endpoint: Incidence of treatment-emergent adverse events
RALLY-MF: A Phase 1b/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of DISC-0974 in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Primary endpoint: Safety and Tolerability of DISC-0974 (Phase 1b only)
Frequently asked questions
Who is developing selcodebart?
selcodebart is being developed by Disc Medicine, Inc..
How many clinical trials involve selcodebart?
BioSniper tracks 3 clinical trials involving selcodebart.